|
GLUE Monte Rosa Therapeutics Inc 1826457 |
| Balance Sheet |
|
Current Assets
|
251,207,000 |
|
Assets
|
315,080,000 |
|
Current Liabilities
|
41,641,000 |
|
Liabilities
|
109,623,000 |
|
Equity
|
205,457,000 |
|
Shares Out
|
61,373,000 |
| Cash Flow Statement |
|
Operating Cash Flow
|
-86,926,000 |
|
Investing Cash Flow
|
-13,556,000 |
| Market Analysis |
Market Cap
|
357,543,809 |
|
Price
|
6.75 |
|
BVPS
|
3.35 |
|
PB
|
1.97 |
|
EPS
|
-2.24 |
|
PS
|
9.70 |
|
FCF
|
-100,482,000 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view GLUE documents filed with the SEC.
GLUE Filings
Clear
